212 related articles for article (PubMed ID: 19799650)
1. Aberrant human leucocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma.
Lin A; Chen HX; Zhu CC; Zhang X; Xu HH; Zhang JG; Wang Q; Zhou WJ; Yan WH
J Cell Mol Med; 2010 Aug; 14(8):2162-71. PubMed ID: 19799650
[TBL] [Abstract][Full Text] [Related]
2. Clinical relevance and functional implications for human leucocyte antigen-g expression in non-small-cell lung cancer.
Lin A; Zhu CC; Chen HX; Chen BF; Zhang X; Zhang JG; Wang Q; Zhou WJ; Hu W; Yang HH; Xu HH; Yan WH
J Cell Mol Med; 2010 Sep; 14(9):2318-29. PubMed ID: 19602033
[TBL] [Abstract][Full Text] [Related]
3. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors?
Rouas-Freiss N; Marchal RE; Kirszenbaum M; Dausset J; Carosella ED
Proc Natl Acad Sci U S A; 1997 May; 94(10):5249-54. PubMed ID: 9144223
[TBL] [Abstract][Full Text] [Related]
4. Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection.
Cai MY; Xu YF; Qiu SJ; Ju MJ; Gao Q; Li YW; Zhang BH; Zhou J; Fan J
Clin Cancer Res; 2009 Jul; 15(14):4686-93. PubMed ID: 19584149
[TBL] [Abstract][Full Text] [Related]
5. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis.
Riteau B; Rouas-Freiss N; Menier C; Paul P; Dausset J; Carosella ED
J Immunol; 2001 Apr; 166(8):5018-26. PubMed ID: 11290782
[TBL] [Abstract][Full Text] [Related]
6. Higher human lymphocyte antigen class I expression in early-stage cancer cells leads to high sensitivity for cytotoxic T lymphocytes.
Akazawa Y; Nobuoka D; Takahashi M; Yoshikawa T; Shimomura M; Mizuno S; Fujiwara T; Nakamoto Y; Nakatsura T
Cancer Sci; 2019 Jun; 110(6):1842-1852. PubMed ID: 30973665
[TBL] [Abstract][Full Text] [Related]
7. Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity.
Cheung PF; Yip CW; Wong NC; Fong DY; Ng LW; Wan AM; Wong CK; Cheung TT; Ng IO; Poon RT; Fan ST; Cheung ST
Cancer Immunol Res; 2014 Dec; 2(12):1209-19. PubMed ID: 25315249
[TBL] [Abstract][Full Text] [Related]
8. HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition.
Riteau B; Menier C; Khalil-Daher I; Martinozzi S; Pla M; Dausset J; Carosella ED; Rouas-Freiss N
Int Immunol; 2001 Feb; 13(2):193-201. PubMed ID: 11157852
[TBL] [Abstract][Full Text] [Related]
9. Expression of the nonclassical HLA class I and MICA/B molecules in human hepatocellular carcinoma.
Chen A; Shen Y; Xia M; Xu L; Pan N; Yin Y; Miao F; Shen C; Xie W; Zhang J
Neoplasma; 2011; 58(5):371-6. PubMed ID: 21744989
[TBL] [Abstract][Full Text] [Related]
10. RNA interfering targeting human leukocyte antigen-G enhanced immune surveillance mediated by the natural killer cells on hepatocellular carcinoma.
Zeng XC; Zhang T; Huang DH; Wang GY; Chen W; Li H; Zhang J; Fang TL; Zhang Q; Chen GH
Ann Clin Lab Sci; 2013; 43(2):135-44. PubMed ID: 23694787
[TBL] [Abstract][Full Text] [Related]
11. Role of HLA-G versus HLA-E on NK function: HLA-G is able to inhibit NK cytolysis by itself.
Khalil-Daher I; Riteau B; Menier C; Sedlik C; Paul P; Dausset J; Carosella ED; Rouas-Freiss N
J Reprod Immunol; 1999 Jul; 43(2):175-82. PubMed ID: 10479053
[TBL] [Abstract][Full Text] [Related]
12. MICA/B expression is inhibited by unfolded protein response and associated with poor prognosis in human hepatocellular carcinoma.
Fang L; Gong J; Wang Y; Liu R; Li Z; Wang Z; Zhang Y; Zhang C; Song C; Yang A; Ting JP; Jin B; Chen L
J Exp Clin Cancer Res; 2014 Sep; 33(1):76. PubMed ID: 25228093
[TBL] [Abstract][Full Text] [Related]
13. HLA-G mediates protection from natural killer cytolysis: implications in immune tolerance.
Carosella ED; Khalil-Daher I; Dausset J; Rouas-Freiss N
Transplant Proc; 1999; 31(1-2):1192-3. PubMed ID: 10083531
[No Abstract] [Full Text] [Related]
14. HLA-G promotes immune tolerance.
Rouas-Freiss N; Paul P; Dausset J; Carosella ED
J Biol Regul Homeost Agents; 2000; 14(2):93-8. PubMed ID: 10841284
[TBL] [Abstract][Full Text] [Related]
15. Fibroblast growth factor-2 enhances NK sensitivity of hepatocellular carcinoma cells.
Tsunematsu H; Tatsumi T; Kohga K; Yamamoto M; Aketa H; Miyagi T; Hosui A; Hiramatsu N; Kanto T; Hayashi N; Takehara T
Int J Cancer; 2012 Jan; 130(2):356-64. PubMed ID: 21351090
[TBL] [Abstract][Full Text] [Related]
16. HLA-G expression in human melanoma cells: protection from NK cytolysis.
Adrián Cabestré F; Moreau P; Riteau B; Ibrahim EC; Le Danff C; Dausset J; Rouas-Freiss N; Carosella ED; Paul P
J Reprod Immunol; 1999 Jul; 43(2):183-93. PubMed ID: 10479054
[TBL] [Abstract][Full Text] [Related]
17. Molecular and immunologic aspects of the nonclassical HLA class I antigen HLA-G: evidence for an important role in the maternal tolerance of the fetal allograft.
Moreau P; Paul P; Rouas-Freiss N; Kirszenbaum M; Dausset J; Carosella ED
Am J Reprod Immunol; 1998 Sep; 40(3):136-44. PubMed ID: 9764357
[TBL] [Abstract][Full Text] [Related]
18. Cancer-testis Antigen OY-TES-1 Expression and Immunogenicity in Hepatocellular Carcinoma.
Luo B; Yun X; Li J; Fan R; Guo WW; Liu C; Lin YD; Ge YY; Zeng X; Bi SQ; Nong WX; Zhang QM; Xie XX
Curr Med Sci; 2020 Aug; 40(4):719-728. PubMed ID: 32862383
[TBL] [Abstract][Full Text] [Related]
19. Expression of HLA-G in patients with hepatocellular carcinoma.
Wang Y; Ye Z; Meng XQ; Zheng SS
Hepatobiliary Pancreat Dis Int; 2011 Apr; 10(2):158-63. PubMed ID: 21459722
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of HLA-G expression via RNAi abolishes resistance of extravillous trophoblast cell line TEV-1 to NK lysis.
Chen LJ; Han ZQ; Zhou H; Zou L; Zou P
Placenta; 2010 Jun; 31(6):519-27. PubMed ID: 20430441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
